Novo Nordisk Market Cap 2006-2018 | NVO

Novo Nordisk market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Novo Nordisk market cap as of November 21, 2018 is $106.64B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $106.636B $16.962B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $392.911B 18.42
Pfizer (PFE) United States $259.128B 14.61
Merck (MRK) United States $201.621B 17.47
Novartis AG (NVS) Switzerland $201.503B 17.22
AbbVie (ABBV) United States $132.506B 11.76
Eli Lilly (LLY) United States $121.525B 21.36
Sanofi (SNY) France $112.036B 13.87
AstraZeneca (AZN) United Kingdom $102.177B 12.69
GlaxoSmithKline (GSK) United Kingdom $100.760B 13.54
Bristol-Myers Squibb (BMY) United States $87.355B 14.39